Kohl's represents good value for patient investors, says RW Baird Baird believes Kohl's represents good value for patient investors citing low expectations and several credible initiatives that are poised to drive comp improvement in the second half of the year. Shares are Outperform rated with a $63 price target.
News For KSS From The Last 14 Days
Check below for free stories on KSS the last two weeks.
Kohl's upgraded to Buy from Neutral at Citigroup Citigroup upgraded Kohl's to Buy on expectations the company's comp store sales and margins will improve due to better product assortment, loyalty program leverage and inventory management. Citi raised its price target for shares to $70 from $63.